Presymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance
dc.contributor.author | Weinbren, Michael | |
dc.date.accessioned | 2022-11-01T15:27:46Z | |
dc.date.available | 2022-11-01T15:27:46Z | |
dc.date.issued | 2022-05 | |
dc.identifier.citation | Moira A. Mugglestone et al. (2022) ‘Presymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance’, BMC Infectious Diseases, 22(1), pp. 1–15 | en_US |
dc.identifier.uri | http://hdl.handle.net/20.500.12904/15928 | |
dc.description.abstract | This is the second of two guidance articles produced by the British Infection Association (BIA), the Healthcare Infection Society (HIS), the Infection Prevention Society (IPS) and the Royal College of Pathologists (RCPath). Both articles refer to the pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Using evidence that emerged during the first wave of the pandemic, the articles summarise aspects of the transmission dynamics of SARS-CoV-2 and provide guidance on how to reduce the risk of transmission. This article focuses on the risks of presymptomatic, asymptomatic and post-symptomatic SARS-CoV-2 transmission, allowing healthcare workers and the public to understand how transmission occurs and to take action to protect themselves and others. The guidance recognises further waves of the pandemic, the possibility of reinfection, the emergence of new variants of the virus and ongoing immunisation programmes. | |
dc.description.uri | https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07440-0 | en_US |
dc.publisher | BMC Infectious Diseases | en_US |
dc.subject | Asymptomatic | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Guideline | en_US |
dc.subject | Infection | en_US |
dc.subject | Post-symptomatic | en_US |
dc.subject | Presymptomatic | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | Transmission | en_US |
dc.title | Presymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance | en_US |
dc.type | Article | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
rioxxterms.version | NA | en_US |
rioxxterms.versionofrecord | 10.1186/s12879-022-07440-0 | en_US |
rioxxterms.type | Journal Article/Review | en_US |
refterms.dateFOA | 2022-11-01T15:27:47Z | |
refterms.panel | Unspecified | en_US |
html.description.abstract | This is the second of two guidance articles produced by the British Infection Association (BIA), the Healthcare Infection Society (HIS), the Infection Prevention Society (IPS) and the Royal College of Pathologists (RCPath). Both articles refer to the pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Using evidence that emerged during the first wave of the pandemic, the articles summarise aspects of the transmission dynamics of SARS-CoV-2 and provide guidance on how to reduce the risk of transmission. This article focuses on the risks of presymptomatic, asymptomatic and post-symptomatic SARS-CoV-2 transmission, allowing healthcare workers and the public to understand how transmission occurs and to take action to protect themselves and others. The guidance recognises further waves of the pandemic, the possibility of reinfection, the emergence of new variants of the virus and ongoing immunisation programmes. | en_US |
rioxxterms.funder.project | 94a427429a5bcfef7dd04c33360d80cd | en_US |